Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page’s software/interface revision indicator updates from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a site/version deployment rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check57 days agoChange DetectedNew revision added to the record history: v3.5.0 appears, indicating updates since the previous revision (v3.4.3).SummaryDifference0.1%

- Check64 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 in the Record History.SummaryDifference0.1%

- Check93 days agoChange DetectedA new revision (v3.4.2) was added to the Record History and the previous revision (v3.4.1) removed, reflecting a minor administrative update; this does not affect study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check100 days agoChange DetectedA new revision entry v3.4.1 was added to the Record History and the v3.4.0 entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.